Skip to content

Survey on Pre-ECT Evaluation and ECT Application

Multicenter Assessment of Pre-Electroconvulsive Therapy (ECT) Evaluation and ECT Application

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04335916
Enrollment
30
Registered
2020-04-07
Start date
2020-04-01
Completion date
2020-11-01
Last updated
2020-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catatonia, Depression, Malignant Neuroleptic, Schizoaffective Disorder, Schizophrenia, Suicidal Intention

Keywords

Electroconvulsive therapy, Pre-ECT evaluation

Brief summary

The aim of this study is to identify specifics of pre-ECT assessments and ECT application in European psychiatric services. We will engage European centres that provide ECT for psychiatric patients and for psychiatric indications. It could bring better insights on current standards and possibly give some further improvements in the field of European ECT practices.

Detailed description

Electroconvulsive therapy (ECT) is an extremely important therapeutic method in the treatment of certain psychiatric conditions. Its' effect has been demonstrated in many clinical trials, and the indications for the use of ECT are clearly defined. Thus, the absolute indications for the use of ECT are catatonia and malignant neuroleptic syndrome, while the relative indications for ECT are therapy-resistant schizophrenia, depression and chronic suicidality. When the lead psychiatrist sets an indication for the use of ECT, pre-ECT evaluation is conducted. Although the pre-evaluation aims to assess the psychophysical condition of the patient and to determine the potential risks and possible side effects of such therapy, no clear algorithm of procedures is specified. There is no data on clear guidelines for the necessary processing prior to the application of ECT, both at national levels and globally. The assessment recommendations, however, are very broad, and most of them are focused on the ethical issues of applying ECT. The standardized pre-ECT evaluation would provide physicians and patients a systematic and evidence-based risk assessment and presumption of adverse reaction profiles.

Interventions

None listed

Sponsors

Klinički Bolnički Centar Zagreb
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* departments that provide pre-ECT assessment * departments that provide ECT application * departments that provide both pre-ECT assessment and ECT application

Exclusion criteria

* departments that used to provide either pre-ECT assessment or ECT application * departments that refer patients for ECT but don't provide pre-ECT assessment

Design outcomes

Primary

MeasureTime frameDescription
pre-ECT evaluation dataBaselineData on pre-ECT evaluation collected with specially designed survey for this research. Pre-ECT evaluation treatment includes are there written or agreed indications, inclusion and exclusion criteria and pre-ECT evaluation, the common neuropsychiatric and somatic evaluation for ECT candidate.
ECT administration dataBaselineData on ECT application collected with specially designed survey for this research. The survey examines the most common methods of applying ECT, provided education and the necessary legal and ethical codes.

Countries

Croatia

Contacts

Primary ContactSara Medved
smedved@kbc-zagreb.hr+38512388888

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026